Abbvie Inc. vs DaVita Inc.
ABBV vs DVA — side-by-side comparison from reported financials. ABBV leads 4, DVA leads 6 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
DaVita Inc.
DVA · Healthcare
$179.25+1.26%Strained
| Metric | ABBV | DVA |
|---|---|---|
| Price | $276.43 | $179.25 |
| Market cap | $488B | $11.4B |
| Revenue (TTM) | $64.4B | $14.0B |
| Revenue growth | +1.8% | +5.5% |
| Net margin | 9.8% | 6.0% |
| Free cash flow | $18.2B | $1.61B |
| Net cash (debt) | ($56.2B) | ($9.57B) |
| 1-year price return | +19.8% | +41.8% |
| P/E | 77.4 | 13.5 |
| P/E vs own history (cheap-side %) | 23% | 54% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | 181% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 8 of 11 |
| Employees | 57,000 | 78,000 |
Full résumé-style profiles: ABBV CV · DVA CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.